Richard A. Meier - 12 May 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
12 May 2023
Net transactions value
-$63.41
Form type
4
Filing time
17 May 2023, 18:14:59 UTC
Previous filing
21 Oct 2022
Next filing
24 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $576,385 +8,500 +7.8% $67.81 117,494 12 May 2023 Direct
transaction BMRN Common Stock Tax liability $576,448 -6,137 -5.2% $93.93 111,357 12 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -8,500 -100% $0.000000* 0 12 May 2023 Common Stock 8,500 $67.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.